Dose-response model for Burkholderia pseudomallei (melioidosis)

Journal of Applied Microbiology

Volumn 105, Issue 5, 2008, Pages 1361-1371

  Tamrakar, S B ^a   Haas, C N ^a  

^a Drexel University   (United States)

Author keywords

BALB c mice; Burkholderia mallei; Burkholderia pseudomallei; C57BL 6 mice; Diabetic rats; Dose response models; Melioidosis

Indexed keywords

MAXIMUM LIKELIHOOD ESTIMATION; POPULATION STATISTICS; RATS;

BALB/C MICE; BURKHOLDERIA MALLEUS; BURKHOLDERIA PSEUDOMALLEI; C57BL/6 MICE; DATA SET; DIABETIC RATS; DOSE RESPONSE RELATIONSHIPS; DOSE-RESPONSE MODELS; GUINEA PIGS; MELIOIDOSIS;

DECISION MAKING;

BACTERIUM; DIABETES; DOSE-RESPONSE RELATIONSHIP; HOST-PATHOGEN INTERACTION; INFECTIOUS DISEASE; MAXIMUM LIKELIHOOD ANALYSIS; MICROBIAL ACTIVITY; POLICY MAKING; POPULATION OUTBREAK; PUBLIC HEALTH; RODENT; SENSITIVITY ANALYSIS;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BAGG ALBINO MOUSE; BURKHOLDERIA PSEUDOMALLEI; CONTROLLED STUDY; DECISION MAKING; DIABETES MELLITUS; GUINEA PIG; INFECTION SENSITIVITY; MELIOIDOSIS; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; PREDICTION; RAT;

ANIMALIA; BURKHOLDERIA MALLEI; BURKHOLDERIA PSEUDOMALLEI; CAVIA; MUS; RATTUS;

EID: 54049126134     PISSN: 13645072     EISSN: 13652672     Source Type: Journal    
DOI: 10.1111/j.1365-2672.2008.03880.x     Document Type: Article

References (34)

1. Anonymous (2007) "Burkholderia description page." Burkholderia Mannual. Retrieved 20 July 2007, from http://pathema.tigr.org/tigr-scripts/ Burkholderia/shared/HtmlPage.cgi?page=burkholderia_description.
2. Barnes, J.L. Ketheesan, N. (2005) Route of infection in melioidosis. Emerg Infect Dis 11, 638 639.
3. Brett, P.J., DeShazer, D. Woods, D.E. (1997) Characterization of Burkholderia pseudomallei and Burkholderia pseudomallei-like strains. Epidemiol Infect 118, 137 148.
4. Brett, P.J. Woods, D.E. (1996) Structural and immunological characterization of Burkholderia pseudomallei O-polysaccharide-flagellin protein conjugates. Infect Immun 64, 2824 2828.
5. Brett, P.J. Woods, D.E. (2000) Pathogenesis of and immunity to melioidosis. Acta Trop 74, 201 210.
6. Currie, B.J., Fisher, D.A., Howard, D.M., Burrow, J.N.C., Selvanayagam, S., Anstey, N.M., Huffam, S.E., Snelling, P.L., et al. (2000a) Endemic melioidosis in tropical Northern Australia: a 10-year prospective study and review of the literature. Clin Infect Dis 31, 981 986.
7. Currie, B.J., Fisher, D.A., Howard, D.M., Burrow, J.N.C., Selvanayagam, S., Snelling, P.L., Anstey, N.M. Mayo, M. (2000b) The epidemiology of melioidosis in Astralia and Papua New Guinea. Acta Trop 74, 121 127.
8. Dannenberg, A.M. Scott, E.M. (1958a) Melioidosis: pathogenesis and immunity in mice and hamsters: II. studies with avirulent strains of Melleomyces pseudomallei. Am J Pathol 34, 1099 1121.
9. Dannenberg, A.M. Scott, E.M. (1958b) Melioidosis: pathogenesis and immunity in mice and hamsters: I. studies with strains of Malleomyces pseudomallei. J Exp Med 107, 153 166.
10. Fritz, D.L., Vogel, P., Brown, D.R., DeShazer, D. Waag, D.M. (2000) Mouse model of sublethal and lethal intraperitoneal glanders (Burkholderia mallei). Vet Pathol 37, 626 636.
11. Gan, Y.H. (2005) Interaction between Burkholderia pseudomallei and the host immune response: sleeping with the enemy? J Infect Dis 192, 1845 1850.
12. Haas, C.N. (1983) Estimation of risk due to low dose of microorganisms: a comparison of alternative methodologies. Am J Epidemiol 118, 573 582.
13. Haas, C.N., Madabusi, A.T., Rose, J.B. Gerba, C.P. (2000) Development of a dose-response relationship for Escherichia coli O157:H7. Int J Food Microbiol 1748, 153 159.
14. Haas, C.N., Rose, J.B. Gerba, C.P. (1999) Quantitative Microbial Risk Assessment. New York : John Wiley and Sons, Inc.
15. Jeddeloh, J.A., Fritz, D.L., Waag, D.M., Hartings, J.M. Andrews, G.P. (2003) Biodefense-driven murine model of pneumonic melioidosis. Infect Immun 71, 584 587.
16. Leakey, A.K., Ulett, G.C. Hirst, R.G. (1998) BALB/c and C57Bl/6 mice infected with virulent Burkholderia pseudomallei provide contrasting animal models for the acute and chronic forms of human melioidosis. Microb Pathog 24, 269 275.
17. Lever, M.S., Nelson, M., Ireland, P.I., Stagg, A.J., Beedham, R.J., Hall, G.A., Knight, G. Titball, R.W. (2003) Experimental aerogenic Burkholderia mallei (glanders) infection in the BALB/c mouse. J Med Microbiol 52, 1109 1115.
18. Ling, J.M.L., Moore, R.A., Surette, M.G. Woods, D.E. (2006) The mviN homolog in Burkholderia pseudomallei is essential for viability and virulence. Can J Microbiol 52, 831 842.
19. Liu, B., Koo, G.C., Yap, E., Chua, H.K.L. Gan, Y.H. (2002) Model of differential susceptibility to mucosal Burkholderia pseudomallei infection. Infect Immun 70, 504 511.
20. Liu, Y., Loh, J.P., Aw, L.T., Yap, E.P., Lee, M.A. Ooi, E.E. (2006) Rapid molecular typing of Burkholderia pseudomallei, isolated in an outbreak of melioidosis in Singapore in 2004, based on variable-number tandem repeats. R Soc Trop Med Hyg 100, 687 692.
21. Merianos, A., Patel, M., Noonan, C., Sharrock, D., Mock, P.A. Currie, B.J. (1993) The 1990-1991 outbreak of melioidosis in the northen territory of Australia: epidemiology and environmental studies. Southeast Asian J Trop Med Public Health 24, 425 435.
22. Miller, W.R., Pannel, L., Cravitz, L., Tanner, W.A. Rosebury, T. (1947) Studies on certain biological characteristics of Malleomyces mallei and Malleomyces pseudomallei II. Virulence and infectivity for animals. J Bacteriol 55, 127 135.
23. Neuhauser, M. Hothorn, L.A. (1999) An exact Cochran-Amritage test for trend when when dose-response shapes are a priori unknown. Comput Statist Data Anal 30, 403 412.
24. Schell, M.A., Ulrich, R.L., Ribot, R.J., Brueggemann, E.E., Hines, H., Chen, B.D., Lipscomb, L., Kim, H.S., et al. (2007) Type VI secretion is a major virulence determinant in Burkholderia mallei. Mol Biol 64, 1466 1485.
25. Sprague, L.D. Neubauer, H. (2004) Melioidosis in animals: a review on epizootiology, diagnosis and clinical presentation. J Vet Med B Infect Dis Vet Public Health 50, 305 320.
26. Stevens, M. P., Haque, A., Atkins, A., Hill, J., Wood, M.W., Easto, A., Nelson, M., Underwood-Fowler, C., et al. (2004) Attenuated virulence and protective efficacy of a Burkholderia pseudomallei bsa type III secretion mutant in murine models of melioidosis. Microbiology 150, 266 267.
27. Suputtamongkol, Y., Chaowagul, W., Chetchotisakd, P., Lertpatanasuwun, N., Intaranongpai, S., Ruchutrakool, T., Budhsarawong, D., Mootsikapun, P., Wuthiekanun, V., Teerawatasook, N. Lulitanond, A. (1999) Risk Factors for Melioidosis and Bacteremic Melioidosis. Clin Infect Dis 29, 408 413.
28. Taweechaisupaponga, S., Kaewpab, C., Arunyanartc, C., Kanlac, P., Homchampad, P., Sirisinhae, S., Proungvitayad, T. Wongratanacheewinf, S. (2005) Virulence of Burkholderia pseudomallei does not correlate with biofilm formation. Microb Pathog 39, 77 85.
29. Thibault, F.M., Hernandez, E., Vidal, D.R., Girardet, M. Cavallo, J.-D. (2004) Antibiotic susceptibility of 65 isolates of Burkholderia pseudomallei and Burkholderia mallei to 35 antimicrobial agents. J Antimicrob Chemother 54, 1134 1138.
30. Ulett, G.C., Currie, B.J., Clair, T.W., Mayo, M., Ketheesan, N., LAbrooyb, J.T., Gal, D., Norton, R., et al. (2001) Burkholderia pseudomallei virulence: definition, stability and association with clonality. Microbes Infect 3, 621 631.
31. Ulett, G. C., Ketheesan, N. Hirst, R.G. (1998) Macrophage-lymphocyte interactions mediate anti-Burkholderia pseudomallei activity. FEMS Immunol Med Microbiol 21, 283 286.
32. Ulett, G.C., Labrooy, J.T., Curried, B.J., Barnese, J.L. Ketheesanb, N. (2005) A model of immunity to Burkholderia pseudomallei: unique responses following immunization and acute lethal infection. Microbes Infect 7, 1263 1275.
33. Woods, D.E. (1995) Psedumonas pseudomallei- insulin interaction. Infect Immun 63, 3745.
34. Woods, D.E., DeShazer, D., Moore, R.A., Brett, P.J., Burtnick, M.N., Reckseidler, S.L. Senkiw, M.D. (1999) Current studies on the pathogenesis of melioidosis. Microbes Infect 2, 157 162.